Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Leader pricing
Leader Pricing, also referred to as Loss Leader is the practice most commonly used by retailers in reducing the price of a high-demand product to be the lowest in its market. This is generally done to draw in trade, the loss on the product often considered a cost of promotion and offset against other items sold.
See also:
Loss leader
Related terms
Economic regulation, Brand strategy, Brand, Investigational new drug (IND), Market leader, Objectives, Reference pricing, Segment, Offensive marketing, Decline Stage, Cost per click (CPC), Competitive advantage, Corporate reputation, Internal analysis, Personal selling,
COVID-19 Updates and Daily News
Featured jobs
-
Head of Copy
-
£ competitive
- Sanofi and Exscientia agree on a deal worth up to $5.2bn for AI-driven therapies
- Pfizer CEO announces plans to launch Omicron-specific COVID-19 vaccine
- Pfizer expands access to lipid nanoparticle technology in new agreement with Acuitas Therapeutics
- Biogen’s Alzheimer’s treatment Aduhelm limited to clinical trial participants in the US
- BMS and 2seventy bio move away from CAR-T programme
- Amgen’s Lumykras receives conditional marketing authorisation from EC
- Live Webinar: Measuring Vital Health Indicators Through Your Camera
- AstraZeneca's Enhertu receives FDA grant for priority review
- Pfizer’s Cibinqo granted FDA approval for adults with moderate-to-severe atopic dermatitis
- Julie Beeso joins Envision Pharma Group in new Global Director, Professional Development and Engagement role
- Live Webinar: Expanding Access to High-Quality Healthcare
- Vir Biotech launches new research programme for HIV and malaria prevention
- Sanofi and Exscientia agree on a deal worth up to $5.2bn for AI-driven therapies
- Why pharma must get smart in its approach to customer engagement
- Pfizer lifts 2021 guidance as sales of its BioNTech-partnered vaccine continue to climb
- Amgen’s Lumykras receives conditional marketing authorisation from EC
- J&J’s COVID-19 booster shows 85% effectiveness in preventing hospitalisation for COVID-19 in study
- Understanding religious and cultural barriers to clinical trial participation
PMHub
Havas Life Medicom
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by...
